Page last updated: 2024-09-03

glycyl-arginyl-glycyl-aspartyl-seryl-proline and Adenocarcinoma

glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casey, RC; Grindle, SM; Koch, KA; Oegema, TR; Pambuccian, SE; Skubitz, AP; Skubitz, KM1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Adenocarcinoma

ArticleYear
Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers.
    Clinical & experimental metastasis, 2003, Volume: 20, Issue:4

    Topics: Adenocarcinoma; Antibodies, Blocking; Antibodies, Monoclonal; Antigens, Neoplasm; Coculture Techniques; Dipeptides; Disintegrins; Epithelium; Female; Humans; Integrin beta1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Neoplasm Invasiveness; Oligopeptides; Ovarian Neoplasms; Protease Inhibitors; Tissue Inhibitor of Metalloproteinases; Tumor Cells, Cultured

2003